BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Xenon Genetics Incorporated

Xenon Genetics is a privately owned, genomics-based drug discovery and development company engaged in identifying genes and other drug targets associated with human disease and developing pharmaceutical therapies based on these genetically-derived targets. Xenon has multiple drug discovery programs in three therapeutic areas: cardiovascular, metabolic and neurological diseases. Each of these areas represents a substantial opportunity for the development of new, more effective therapies targeting unmet clinical needs.


Contact Details:
650 Gilmore Way
Burnaby
British Columbia
V5G 4W8
Canada
Tel:604-484-3300
Fax:604-484-3450
Email:info@xenongenetics.com
WWW:

www.xenongenetics.com/




Loading...

Recent Publications by Xenon Genetics Incorporated:

Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates.
Hereditary sensory and autonomic neuropathy (HSAN) type II is an autosomal...
4th June, 2004
Xenon Genetics Research, Xenon Genetics Inc., Burnaby, British Columbia Am J Hum Genet. 2004 May;74(5):1064-73. Epub 2004 Apr 1.
DOI Direct Link

BioNews Results for Xenon Genetics Incorporated:

Upstream Biosciences Appoints Dr. Michael Hayden Killam Professor of Medical Genetics and the Canada
Interest!ALERT:  Oct 2 2008 4:07AM Matching: xenon genetics
Upstream Biosciences Appoints Dr. Michael Hayden Killam Professor of Medical Genetics and the Canada Research
Macro World Investor:  Oct 1 2008 1:17PM Matching: xenon genetics
Upstream Biosciences Appoints Dr. Michael Hayden Killam Professor of Medical Genetics and the Canada Research
Calibre Macro World:  Oct 1 2008 1:02PM Matching: xenon genetics
Upstream Biosciences Appoints Dr. Michael Hayden Killam Professor of Medical Genetics and the Canada Research
Earthtimes.org:  Oct 1 2008 1:42PM Matching: xenon genetics

Xenon Genetics Incorporated Patents:

US Patent No.Title
7256028 Methods for screening compounds that modulate lipid metabolism
7166584 Cholesterol transport gene
6759208 High throughput screening assays using fatty acid synthetic enzymes
6617122 Process for identifying modulators of ABC1 activity

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 237 times since April 2007, the link to the organisation's website has been followed 37 times

Search for more companies in Burnaby

Search for more companies in British Columbia



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Xenon Genetics Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.